]>
IRCT20200623047893N1 IRCT 2020-07-26 Shiraz University of Medical Sciences "coenzyme Q10 and L carnitine in Benign prismatic hyperplasia" Effect of combination therapy of coenzyme Q10 and L carnitine and finasteride on treatment management in patients with lower urinary tract symptoms ( LUTS) due to benign prismatic hyperplasia (BPH) 2020-06-25 anticipated 50 Complete https://irct.ir/trial/49128 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization is done by the method of 4 blocks. The study is based on random allocation and is done by block balanced randomization method. Preparing a list of blocks and assigning numbers to them, selecting random numbers between 1 and 6, specifying the treatment allocation list, Blinding description: This study is a double-blind clinical trial. Thus, the study at the level of the patient and the evaluator of the outcome of the results became blind. The drug and placebo capsules were divided into four-block blocks before filling. Only the researcher could decipher the contents of each capsule based on the original stored form of the random results. The person in charge of delivering the medicine, the patient, the doctor, and the person in charge of evaluating the consequences were not aware of the coding.The results of the control and intervention group under the headings of groups A and B were delivered to the statistical analyst. 3 Condition 1: Benign prostatic hyperplasia. Condition 2: Lower urinary tract symptoms. Intervention 1: Intervention group: finasteraid, coenzyme Q10 100 mg , L carnitine 1000mg ,1tablet daily for 8 weeks. Intervention 2: Control group: finasteraid, plasebo ,1tablet daily for 8 weeks. Yes - There is a plan to make this available What will be shared: Part of the data can be shared When: 6 months after printing the results To whom: Employed researchers Conditions: Employed researchers Where to obtain: Mahsa norouzi ,mahsanorouzi89@gmail.com How to obtain: Email Comments:
public Mahsa norouzi
No 18 , niyayesh 5 Are, Tohidy tad Blvd, Shiraz Town
Shiraz Iran (Islamic Republic of) 713451978 +98 71 3822 9875 mahsanorouzi89@gmail.com Shiraz University of Medical Sciences scientific Mahsa norouzi
No18, niyayesh Ave , tohidy rad Blvd, Shiraz Town
Shiraz Iran (Islamic Republic of) 713451978 +98 71 3822 9875 mahsanorouzi89@gmail.com Shiraz University of Medical Sciences Iran (Islamic Republic of) 50-75 years old IPSS=8-19 Prostate volume 40-60 cc 50 years 75 years Male urinary tract infections severe liver disease diabetes recent treatment with 5 alpha reductase recent treatment with phototherapy treatment with antiandrogens and antidepressants neurological bladder bladder cancer prostate cancer Take atorvastatin blood pressure Treatment - Drugs Placebo Intervention group: finasteraid, coenzyme Q10 100 mg , L carnitine 1000mg ,1tablet daily for 8 weeks Control group: finasteraid, plasebo ,1tablet daily for 8 weeks Changes in prostate volume. Timepoint: The beginning the study and the end of study. Method of measurement: Sonography. IIEF. Timepoint: The beginning and the end of study. Method of measurement: Questionnaire. Shiraz University of Medical Sciences Approved 2018-04-11 Ethics committee of Shiraz University of Medical sciences No 18, niyayesh 5 Ave,tohidy rad Blvd, Shiraz Town Shiraz Fars Iran (Islamic Republic of)